147 results on '"Barnes E."'
Search Results
2. Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation
3. P313 An overview of body composition and metabolic markers in adults with cystic fibrosis: a single centre analysis
4. Immunotherapy: PHASE 1 CLINICAL TRIAL OF CD19 CAR-T CELLS MANUFACTURED AT THE POINT-OF-CARE
5. EE37 Cost-Utility Analysis of Elecsys Gaad Algorithm Versus Ultrasound Plus -Fetoprotein (AFP) for HCC Surveillance in Patients With Compensated Liver Cirrhosis in the United Kingdom (UK)
6. Early-Stage Endometrial Ca with Multifocal LVSI – Adjuvant Radiation Treatment Choice
7. Salvage Interstitial Brachytherapy for Treatment of Recurrent Endometrial Cancers in the Vagina: 7-Year Single Institution Experience
8. Immunotherapy: PHASE 1 CLINICAL TRIAL OF CD19 CAR-T CELLS MANUFACTURED AT THE POINT OF CARE USING THE MILTENYI CLINIMACS PRODIGY®
9. Clinical Outcomes of Radiotherapy in Vaginal and Vulvar Melanoma: A High-volume Centre's Experience With a Rare Disease
10. Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub-Saharan Africa and South East Asia
11. JOINT REPAIR EVALUATED AUTOMATICALLY ON RADIOGRAPHS IS ASSOCIATED WITH PAIN AND SYNOVIAL FLUID MARKER CHANGES AFTER KNEE JOINT DISTRACTION TREATMENT
12. Relationship of Urethral Dose and Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy
13. Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus (SPARTACUS): A Multicenter Prospective Trial Evaluating Acute Toxicities and Patient Reported Outcomes
14. Place-of-care manufacturing of car19-t cells using an automated closed-system device
15. Dysfonctions vésicosphinctériennes chez les patients atteints de dysautonomie familiale : une étude prospective
16. SBRT For Head and Neck Skin Cancer: An Initial Experience in 106 Medically Unfit Patients
17. Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic and Oligoprogressive Gynecologic Cancers: Clinical Outcomes of a Single Institution Analysis
18. Integrated Intraoperative MRI-Guided Brachytherapy for Cervical Cancer: An Institutional Experience of Treatment Workflow, Planning and Patient Toxicities
19. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study
20. Updated results of activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601)
21. Public health England HCV resistance group: overview and consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection
22. Disparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)
23. MRI-Guided Brachytherapy PLAN Optimization with Three Versus FOUR Fraction Treatment for Locally Advanced Cervical Cancer
24. Acute and Late Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy
25. A Multicenter Analysis of the Utility of MRI Based ADC Image Sets in Delineating GTVres Volumes in Cervical Brachytherapy
26. A Survey of Radiotherapy Practices in Post-operative Endometrial Cancer
27. Opioid Consumption and Pain in Gynecological Cancer Patients that Underwent Spinal Anesthesia for Interstitial Brachytherapy
28. SUN-326 CLINICAL MANIFESTATIONS AND LONG-TERM OUTCOMES OF IGG4-RELATED KIDNEY AND RETROPERITONEAL INVOLVEMENT IN A UNITED KINGDOM IGG4-RELATED DISEASE COHORT
29. PRM174 - OPERATING SYSTEM UPGADES DO NOT ADVERSELY AFFECT ECOA COMPLETION BEHAVIOR WHEN USING A BRING YOUR OWN DEVICE (BYOD) APP.
30. PRM172 - LEARNINGS ON BRING YOUR OWN DEVICE UPTAKE FOR ECOA IMPLEMENTATION: A TALE OF TWO STUDIES
31. Clinical application of the 2011 cancer cachexia consensus
32. Efficacy of Prophylactic Radiotherapy in the Treatment of Heterotopic Ossification
33. Rolling circle amplification and nanopore-based deep sequencing of full-length HBV genomes
34. Highly immunogenic virally vectored T cell vaccine against HCV are able to induce specific CD4+ T cell helper responses
35. A novel chimpanzee adenoviral vectored HBV vaccine, encoding multiple HBV antigens with a shark invariant chain adjuvant, for use in HBV immunotherapy
36. Liver function assessment using magnetic resonance imaging with gadoxetic acid administration
37. HepFree: Screening migrant patients for viral hepatitis in primary care. A 90,000 patient randomised controlled trial indicates benefits are most obvious in older patients
38. Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection
39. A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes
40. Platelet and spleen volume criteria exclude more oesophageal varices needing treatment than Baveno VI criteria with 100% sensitivity
41. Characterization of topology optimized Ti-6Al-4V components using electron beam powder bed fusion
42. Contouring and Target Variability in Vaginal Tumors Treated with MR-Based Interstitial Brachytherapy: A Multi-institutional Contouring Study
43. Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature
44. No change in hepatitis C virus-specific T cell functionality after successful DAA treatment in chronic hepatitis C patients
45. Characterisation of resistance associated substitutions in direct acting antivirals treatment naive patients with genotype 3 hepatitis C virus
46. Distinct immune and regulatory functions of IgG1+ and IgG4+ B cells in IgG4-related disease
47. An AGITG trial –A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel +/-radioTherapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma
48. Plasma lipidomic profiles improve upon conventional risk factors to predict cardiovascular events
49. EP-1432: Predicting pain response after conventional radiotherapy in 1018 patients with bone metastases
50. CD161intCD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.